Pfizer, Flynn Pharma Find New UK Competition Fine No Better

By Nadia Dreid (October 26, 2022, 6:05 PM EDT) — Pfizer and Flynn Pharma are unhappy with the recently reevaluated £70 million ($81 million) fine doled out by Britain’s competition regulator after they won an appeal of the original £89 million assessment, so they’re taking the matter back to the Competition Appeal Tribunal….

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

• Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
• Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
• Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

No Byline Policy

Editorial Guidelines

Corrections Policy

Source